2024-03-29T02:35:38Z
https://niigata-u.repo.nii.ac.jp/oai
oai:niigata-u.repo.nii.ac.jp:00021177
2022-12-15T03:51:46Z
453:456
471:537:538:1178
Cytogenetic Analysis of Methotrexate (MTX) Resistant Mechanisms using a New Human Leukemia Cell Line with Double Minute Chromosomes : Induction of MTX Resistance and Amplification of Dihydrofolate Reductase Gene
微小染色体を有する新しいヒト白血病細胞株でのメソトレキセート耐性機構に関する細胞遺伝学的検討 : ジヒドロ葉酸還元酵素遺伝子の増幅を中心に
微小染色体を有する新しいヒト白血病細胞株でのメソトレキセート耐性機構に関する細胞遺伝学的検討 : ジヒドロ葉酸還元酵素遺伝子の増幅を中心に
斎藤, 弘行
129831
KY821(human myeloblastic leukemia cell line)
double minute chromosomes
methotrexate resistance
dihydrofolate reductase
gene amplification
To obtain drug resistance in newly established AML cell line KY821 with double minute chromosomes (DMs) and its subclone KY821A3 without DMs, they were cultured in increasing concentrations of methotrexate (MTX). KY821 became resistant against 2×10^<-4>M MTX (KY821/MTX), whereas KY821A3 did against 2×10^<-5>M MTX (KY821A3/MTX) in a same period. Enhanced enzyme activities of DHFR corresponded to increased DMs numbers and to amplifications of dihydrofolate reductase (DHFR) gene in both resistant clones. The amplified DHFR gene was proved to be located on DMs by in situ hybridization. These data indicated that the presence of DMs in KY821 would facilitate an aquisition of drug resistance. Unstable MTX resistance was shown to be associated with unstability of amplified DHFR gene located on DMs, and the massage (mRNA) of DHFR was less stable than gene amplification or cytogenetic alteration (DMs). In conclusion, KY821 is a very unique and valuable human leukemic cell line for studies of drug resistance and gene amplification.
departmental bulletin paper
新潟医学会
1992-01
application/pdf
新潟医学会雑誌
1
106
37
48
新潟医学会雑誌
AN00182415
00290440
https://niigata-u.repo.nii.ac.jp/record/21177/files/106(01)_37-48.pdf
jpn